XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 26, 2023
Mar. 31, 2024
Mar. 26, 2023
Income Statement [Abstract]        
Revenue $ 3,793,558 $ 3,869,569 $ 11,033,879 $ 14,221,259
Cost of goods sold 1,977,820 2,197,237 5,783,087 7,835,743
Restructuring charges, net - cost of goods sold 15,202 66,720 38,099 66,720
Total cost of goods sold 1,993,022 2,263,957 5,821,186 7,902,463
Gross margin 1,800,536 1,605,612 5,212,693 6,318,796
Research and development 512,274 429,451 1,404,615 1,325,211
Selling, general, and administrative 215,904 193,500 651,770 632,922
Restructuring charges, net - operating expenses 15,246 40,408 18,955 40,408
Total operating expenses 743,424 663,359 2,075,340 1,998,541
Operating income 1,057,112 942,253 3,137,353 4,320,255
Other income (expense), net 36,073 (3,331) 68,513 (74,660)
Income before income taxes 1,093,185 938,922 3,205,866 4,245,595
Income tax expense (127,359) (124,914) (398,376) (537,201)
Net income $ 965,826 $ 814,008 $ 2,807,490 $ 3,708,394
Net income per share:        
Basic (in dollars per share) $ 7.38 $ 6.03 $ 21.32 $ 27.28
Diluted (in dollars per share) $ 7.34 $ 6.01 $ 21.22 $ 27.20
Number of shares used in per share calculations:        
Basic (in shares) 130,838 134,924 131,663 135,945
Diluted (in shares) 131,518 135,395 132,282 136,314